Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Tom C. Zwart"'
Autor:
Jasper Kamp, Tom C. Zwart, Soufian Meziyerh, Paul J. M. van der Boog, Esther E. Nijgh, Koen van Duin, Aiko P. J. de Vries, Dirk Jan A. R. Moes
Publikováno v:
Pharmaceutics, Vol 16, Iss 1, p 17 (2023)
Background: Meltdose tacrolimus (Envarsus®) has been marketed as a formulation achieving a more consistent tacrolimus exposure. Due to the narrow therapeutic window of tacrolimus, dose individualization is essential. Relaxation of the upper age limi
Externí odkaz:
https://doaj.org/article/823bbd9525af48018c12a9c5f0e33213
Autor:
Tom C. Zwart, Birgit C. P. Koch, Laura E J Peeters, Teun van Gelder, Jorie Versmissen, Soma Bahmany, Joost Daemen, Lida Feyz, Edon Hameli
Publikováno v:
Therapeutic Drug Monitoring, 42(3), 460-467. Lippincott Williams & Wilkins
Background: Drug nonadherence is one of the major challenges faced by resistant hypertension patients, and identification of this problem is needed for optimizing pharmacotherapy. Dried blood spot (DBS) sampling is a minimally invasive method designe
Autor:
Henk-Jan Guchelaar, Tom C. Zwart, Dirk Jan A.R. Moes, Teun van Gelder, Jesse J. Swen, Johan W. de Fijter, Paul J M van der Boog
Publikováno v:
Drug Discovery Today, 26(11), 2527-2546. ELSEVIER SCI LTD
Immunosuppressive therapy is pivotal for sustained allograft and patient survival after renal transplantation. However, optimally balanced immunosuppressive therapy is challenged by between-patient and within-patient pharmacokinetic (PK) variability.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b1bbb7c1b4bd8fcf75cbaf1942e9a7f
https://hdl.handle.net/1887/3263769
https://hdl.handle.net/1887/3263769
Autor:
Suzanne Bezstarosti, Tom C. Zwart, Federica R. Achini, Marco W. Schilham, Dirk Jan A. R. Moes, Marlies E. J. Reinders, Johan W. de Fijter, Sebastiaan Heidt
Publikováno v:
Transplantation. 106:S166-S166
Autor:
Tom C. Zwart, Paul J M van der Boog, Johan W. de Fijter, Aline G.J. Engbers, Ruth E Dam, Dirk Jan A.R. Moes, Ron J. Keizer, R Neil Dalton, Jesse J. Swen, Aiko P. J. de Vries, Henk-Jan Guchelaar
Publikováno v:
Clinical Pharmacokinetics
Clinical Pharmacokinetics, 60, 1201-1215. ADIS INT LTD
Clinical Pharmacokinetics, 60, 1201-1215. ADIS INT LTD
Background Iohexol plasma clearance-based glomerular filtration rate (GFR) determination provides an accurate method for renal function evaluation. This technique is increasingly advocated for clinical situations that dictate highly accurate renal fu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5cc176decdc835c001211ed678ca8ca
https://hdl.handle.net/1887/3196266
https://hdl.handle.net/1887/3196266
Autor:
Henk-Jan Guchelaar, Nielka P. van Erp, Ron J. Keizer, Rob ter Heine, Dirk Jan A.R. Moes, Johan W. de Fijter, Paul J M van der Boog, Tom C. Zwart
Publikováno v:
Clinical Pharmacokinetics, 60, 2, pp. 191-203
Clinical Pharmacokinetics, 60, 191-203
Clinical Pharmacokinetics, 60, 191-203. ADIS INT LTD
Clinical Pharmacokinetics
Clinical Pharmacokinetics, 60, 191-203
Clinical Pharmacokinetics, 60, 191-203. ADIS INT LTD
Clinical Pharmacokinetics
Background and Objective The immunosuppressant everolimus is increasingly applied in renal transplantation. Its extensive pharmacokinetic variability necessitates therapeutic drug monitoring, typically based on whole-blood trough concentrations (C0).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6084d084b4a3117478b85e418ccbefa
Autor:
Mercè Brunet, Eberhard Wieland, Alexander A. Vinks, Pierre Wallemacq, Nils Tore Vethe, Nicolas Picard, Dirk Jan A.R. Moes, Mariadelfina Molinaro, Paweł K. Kunicki, Klemens Budde, Satohiro Masuda, Maja Theresa Dieterlen, Tomoyuki Mizuno, Stein Bergan, Laure Elens, Anders Åsberg, Olga Millán, Florian Lemaitre, Burkhard Tönshoff, Maria Shipkova, Jesse J. Swen, Teun van Gelder, Tomasz Pawinski, Vincent Haufroid, Ofelia Noceti, Tom C. Zwart, Pierre Marquet, Smita Pattanaik, Jean-Baptiste Woillard, Loralie J. Langman, Markus J. Barten, Dennis A. Hesselink, Ron H.N. van Schaik, Michael Oellerich, Christoph Seger, Linda Salzmann, Kamisha L. Johnson-Davis, Raman Venkataramanan
Publikováno v:
Therapeutic Drug Monitoring, Vol. 43, no.2, p. 150-200 (2021)
Therapeutic Drug Monitoring
Therapeutic Drug Monitoring, Lippincott, Williams & Wilkins, 2021, 43 (2), pp.150-200. ⟨10.1097/FTD.0000000000000871⟩
Therapeutic Drug Monitoring, 2021, 43 (2), pp.150-200. ⟨10.1097/FTD.0000000000000871⟩
Therapeutic Drug Monitoring, 43(2), 150-200. LIPPINCOTT WILLIAMS & WILKINS
Therapeutic Drug Monitoring
Therapeutic Drug Monitoring, Lippincott, Williams & Wilkins, 2021, 43 (2), pp.150-200. ⟨10.1097/FTD.0000000000000871⟩
Therapeutic Drug Monitoring, 2021, 43 (2), pp.150-200. ⟨10.1097/FTD.0000000000000871⟩
Therapeutic Drug Monitoring, 43(2), 150-200. LIPPINCOTT WILLIAMS & WILKINS
When mycophenolic acid (MPA) was originally marketed for immunosuppressive therapy, fixed doses were recommended by the manufacturer. Awareness of the potential for a more personalized dosing has led to development of methods to estimate MPA area und
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50b1cf2bb23290633f56b83d70251d51
https://hdl.handle.net/2078.1/249100
https://hdl.handle.net/2078.1/249100
Autor:
Sumit R.M. Gokoel, Johan W. de Fijter, Dirk Jan A.R. Moes, Tom C. Zwart, Paul J M van der Boog
Publikováno v:
Therapeutic Drug Monitoring, 42(5), 702-709. LIPPINCOTT WILLIAMS & WILKINS
Background High intrapatient variability (IPV) in tacrolimus exposure has been associated with an increased risk of graft rejection and graft loss. It has been suggested that medication nonadherence has high impact on IPV. The objective of this study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::618cf5112f542f7287ed1a532137f232
https://hdl.handle.net/1887/3182074
https://hdl.handle.net/1887/3182074
Autor:
Jeroen A. Janson, Marlies E.J. Reinders, Soufian Meziyerh, Ronald W. van Etten, Dirk Jan A.R. Moes, Tom C. Zwart, Teun van Gelder, Aiko P. J. de Vries, Johan W. de Fijter, Ian P.J. Alwayn
Publikováno v:
American Journal of Transplantation, 20(7), 1896-1901. WILEY
American Journal of Transplantation
American Journal of Transplantation
The current coronavirus disease 2019 (COVID‐19) pandemic requires extra attention for immunocompromised patients, including solid organ transplant recipients. We report on a case of a 35‐year‐old renal transplant recipient who suffered from a s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3468aa2e98bc84c2db1cae96e215ce25
https://doi.org/10.1111/ajt.15943
https://doi.org/10.1111/ajt.15943
Autor:
Dina M. Kweekel, Johan W. de Fijter, Tom C. Zwart, Paul J M van der Boog, Henk-Jan Guchelaar, Dirk Jan A.R. Moes, Jesse J. Swen, Sumit R.M. Gokoel
Publikováno v:
British Journal of Clinical Pharmacology. 84:2889-2902
Aims Tacrolimus and mycophenolic acid dosing after renal transplantation is individualized through therapeutic drug monitoring (TDM). Home-based dried blood spot (DBS) sampling has the potential to replace conventional TDM sampling at the clinic. A l